+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Oxidative Stress Assay Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2023

Pre Book Price: $ 5216

Original Price: $ 5795

Oxidativestress isinitiated by the presence of a reactive oxygen species (ROS) which the cell fails to counterbalance and then it damages the biomolecules such as DNA, RNA, lipids and proteins. Oxidative stress has been associated with the aging process as well as various other disease states.It is an ongoingprocess between highly reactive radicals and the body system designed for mitigating their effects.Few diseases occur from a failure to counter these effects. Oxidative stress causes many pathophysiological disorders in the body and some of these include neurodegenerative diseases such as Alzheimer’s disease and Parkinson's disease, cancers, fragile X syndrome, chronic fatigue syndrome, atherosclerosis, heart and blood vessel disorders, cardiovascular disease, inflammatory diseases and others.Oxidative stress assay is a method for detecting and screening markers of oxidative stress in cells. It is a great tool for analyzing and evaluating the capacity to counter the oxidative stress as it provides relevant biological information.

Furthermore, progresses are made in the field of oxidative stress assay markets are technologically advanced equipment with updated technologies to produce high efficiency and accuracy in the testing of oxidative stress.Rapid growth in the pharmaceutical and biotechnological industry, robust trend of research and development, investments in the healthcare sectors, up gradation oftechnology such as content screening for drug discovery, and government subsidy for life science research are the prime growth drivers for oxidative stress assay market. However, there are fewhindrances in the growth of the market; these arelack of awareness, emerging technologies, increased cost of instruments and lack of qualified professionals.

The oxidative stress assay market can be segmented as products, test types, technologies, end users and disease type.

Product types of oxidative stress assay market are divided on the basis of consumables and instruments. Consumables arecategorized as kits and reagents, buffers and chemicals, microplates and antibodies and reagents. The consumables segment in the product type is largest inthe market and is expected to grow at the fastest rate in near future. The main reason for it are clinical advances and increased use incontract research organizations (CRO) and biotechnological industries.

The test type can be divided as reactive oxygen species (ROS)-based assays and enzyme-based assays, antioxidant capacity assays.

Based ontechnologies the market is divided as ELISA, chromatography and microscopy.

Oxidative stress assay market can be broadly divided into disease types such as cardiovascular disease, diabetes, chronic obstructive pulmonary disease (COPD), cancer and asthma.

The end users for oxidative stress assay market are categorized as clinical laboratories, pharmaceutical companies, contract research organizations (CRO) and biotechnological companies.

Geographically the market for oxidative stress assay market are divided as North America, Europe, Asia Pacific, Latin America and Rest of the world.There are some major reasons, responsible for their dominance in this market are increasing number of aged population and high levels of public awareness and innovative technologies. North America and Europe are in the leading position in this market due to their highly advanced technology and infrastructure compared to the improving infrastructure in emerging regions. However, Asia Pacific is estimatedto grow in oxidative stress assay market in future for number of factors such as government initiatives, growing awareness and increased investment in healthcare sector. 

Some of the key players in the oxidative stress assay marketbased on pharmaceutical and biotechnological companies are Abcam Plc., BioVision, Inc., Cell Biolabs, Inc., Merck and Co., Inc., Oxford Biomedical Research, Promega Corporation,Sigma-Aldrich Corporation and Thermo Fisher Scientific, Inc., while the leading clinical laboratories are Alliance Imaging, Inc., Array BioPharma Inc., Genoptix, Inc. and Quest Diagnostics. 

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

It provides distinctive graphics and exemplified SWOT analysis of major market segments

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

To receive discount, please click on the button below.

Please click on the button below to customize this report.

Back To Top